The first half of Honkai Star Rail 3.4 is on the verge of expiring, and Trailblazers will soon be introduced to the second half. The upcoming phase is set to debut on July 23, 2025 (UTC+8).

FURVENT is a global, pivotal 3 arm Phase 3 clinical trial of firmonertinib in first-line non-squamous locally advanced or metastatic NSCLC patients with exon 20 insertion mutations being conducted ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that a randomized, double-masked, vehicle-controlled, Phase 3 study to evaluate the efficacy and safety of pimecrolimus 0. ...

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with obstructive sleep apnea (OSA).

The Ashes of Creation Alpha 2 Phase 3 release date is pushed back, as developer Intrepid polishes the ambitious new MMORPG’s next update.

In other recent news, Abivax has completed enrollment for its two Phase 3 induction trials for the drug obefazimod, aimed at treating ulcerative colitis.

Roche’s hopes of getting astegolimab to regulators this year took a hit after the anti-ST2 antibody failed to reduce flare-ups in a phase 3 study.

GUNTUR: In a major push to Guntur’s long-stalled infrastructure development, the phase-3 of the city’s Inner Ring Road (IRR) project is finally moving forward.

OncoZenge Appoints Meribel Pharma as CDMO for BupiZenge™ Phase 3 Project OncoZenge AB ("OncoZenge" or "the Company") today announced it has engaged Meribel Pharma Solutions ("Meribel," formerly ...

AstraZeneca’s plans to get an amyloidosis drug to market look further out of reach after the pharma’s anti-fibril antibody failed to reduce deaths and hospitalizations in a key phase 3 study ...

Despite a phase 3 flop, Bristol Myers Squibb—encouraged by “clinically meaningful results” and bruised by three other recent pivotal trial failures—still plans to discuss a potential ...

Lyell Immunopharma's LYL314 CAR-T therapy shows durable responses in advanced LBCL patients. Learn about trials and upcoming milestones.